{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:47:03Z","timestamp":1764510423520},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s12185-012-1127-5","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T16:43:55Z","timestamp":1341074635000},"page":"247-253","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan"],"prefix":"10.1007","volume":"96","author":[{"given":"Mihoko","family":"Yotsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ajisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Uehira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igen","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Fukutake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,1]]},"reference":[{"issue":"5","key":"1127_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11912-007-0052-x","volume":"9","author":"A Noy","year":"2007","unstructured":"Noy A. Update on HIV lymphoma. Curr Oncol Rep. 2007;9(5):384\u201390.","journal-title":"Curr Oncol Rep."},{"issue":"7","key":"1127_CR2","first-page":"2319","volume":"93","author":"A Carbone","year":"1999","unstructured":"Carbone A, Gloghini A, Larocca LM, Antinori A, Falini B, Tirelli U, Dalla-Favera R, Gaidano G. Human immunodeficiency virus-associated Hodgkin\u2019s disease derives from post-germinal center B cells. Blood. 1999;93(7):2319\u201326.","journal-title":"Blood"},{"issue":"12","key":"1127_CR3","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","volume":"108","author":"RJ Biggar","year":"2006","unstructured":"Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS. Blood. 2006;108(12):3786\u201391.","journal-title":"Blood"},{"issue":"12","key":"1127_CR4","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"EA Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ. Trends in cancer risk among people with AIDS in the United States 1980\u20132002. AIDS. 2006;20(12):1645\u201354.","journal-title":"AIDS"},{"key":"1127_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1758-2652-14-16","volume":"14","author":"N Dauby","year":"2011","unstructured":"Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N. Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. J Int AIDS Soc. 2011;14:16.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"1127_CR6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","volume":"103","author":"MS Shiels","year":"2011","unstructured":"Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103(9):753\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1127_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.04934.x","volume":"125","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Chow KU, Wolf E, Faetkenheuer G, Stellbrink HJ, van Lunzen J, Jaeger H, Stoehr A, Plettenberg A, Wasmuth JC, Rockstroh J, Mosthaf F, Horst HA, Brodt HR. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin\u2019s disease. Br J Haematol. 2004;125(4):455\u201362.","journal-title":"Br J Haematol"},{"issue":"1","key":"1127_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11908-009-0075-6","volume":"12","author":"ML Nguyen","year":"2010","unstructured":"Nguyen ML, Farrell KJ, Gunthel CJ. Non-AIDS-defining malignancies in patients with HIV in the HAART era. Curr Infect Dis Rep. 2010;12(1):46\u201355.","journal-title":"Curr Infect Dis Rep"},{"key":"1127_CR9","doi-asserted-by":"crossref","unstructured":"Spina M, Carbone A, Gloghini A, Serraino D, Berretta M, Tirelli U. Hodgkin\u2019s disease in patients with HIV infection. Adv Hematol. 2011, pii:402682 [Epub ahead of print].","DOI":"10.1155\/2011\/402682"},{"issue":"2","key":"1127_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3324\/haematol.10479","volume":"92","author":"B Xicoy","year":"2007","unstructured":"Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, Valencia ME, Abella E, Lopez-Guillermo A, Sureda A, Morgades M, Navarro JT, Esteban H. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin\u2019s lymphoma. Haematologica. 2007;92(2):191\u20138.","journal-title":"Haematologica"},{"issue":"6","key":"1127_CR11","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1182\/blood-2002-03-0989","volume":"100","author":"M Spina","year":"2002","unstructured":"Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E, Mena M, Antinori A, Ammassari A, Talamini R, Vaccher E, di Gennaro G, Tirelli U. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood. 2002;100(6):1984\u20138.","journal-title":"Blood"},{"issue":"4","key":"1127_CR12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12185-008-0073-8","volume":"87","author":"H Nagai","year":"2008","unstructured":"Nagai H, Iwasaki N, Odawara T, Okada S. Actual status of AIDS-related lymphoma management in Japan. Int J Hematol. 2008;87(4):442\u20133.","journal-title":"Int J Hematol"},{"key":"1127_CR13","doi-asserted-by":"crossref","unstructured":"The world health organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int. 2000; 50(9):696\u2013702.","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"1127_CR14","doi-asserted-by":"crossref","unstructured":"Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA: Cancer J Clin. 2011; 61(4):212\u201336.","DOI":"10.3322\/caac.20121"},{"issue":"21","key":"1127_CR15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","volume":"339","author":"D Hasenclever","year":"1998","unstructured":"Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease. N Engl J Med. 1998;339(21):1506\u201314.","journal-title":"N Engl J Med"},{"issue":"5","key":"1127_CR16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00002030-200003310-00011","volume":"14","author":"D Serraino","year":"2000","unstructured":"Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, Ballarini P, Pezzotti P, Smacchia C, Pesce A, Ippolito G, Franceschi S, Rezza G. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS. 2000;14(5):553\u20139.","journal-title":"AIDS."},{"issue":"1","key":"1127_CR17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00126334-200309010-00013","volume":"34","author":"S Franceschi","year":"2003","unstructured":"Franceschi S, Dal Maso L, Pezzotti P, Polesel J, Braga C, Piselli P, Serraino D, Tagliabue G, Federico M, Ferretti S, De Lisi V, La Rosa F, Conti E, Budroni M, Vicario G, Piffer S, Pannelli F, Giacomin A, Bellu F, Tumino R, Fusco M, Rezza G. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr. 2003;34(1):84\u201390.","journal-title":"J A cquir Immune Defic Syndr"},{"issue":"1","key":"1127_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2011-02-339275","volume":"118","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Rosenberg PS, Fily F, Lascaux AS, Martinez V, Partisani M, Poizot-Martin I, Rouveix E, Engels EA, Costagliola D, Goedert JJ. HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood. 2011;118(1):44\u20139.","journal-title":"Blood"},{"issue":"10","key":"1127_CR19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0959-8049(01)00105-8","volume":"37","author":"R Dolcetti","year":"2001","unstructured":"Dolcetti R, Boiocchi M, Gloghini A, Carbone A. Pathogenetic and histogenetic features of HIV-associated Hodgkin\u2019s disease. Eur J Cancer. 2001;37(10):1276\u201387.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1127_CR20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12185-010-0712-8","volume":"92","author":"M Ogura","year":"2010","unstructured":"Ogura M, Itoh K, Kinoshita T, Fukuda H, Takenaka T, Ohtsu T, Kagami Y, Tobinai K, Okamoto M, Asaoku H, Sasaki T, Mikuni C, Hirano M, Chou T, Ohnishi K, Ohno H, Nasu K, Okabe K, Ikeda S, Nakamura S, Hotta T, Shimoyama M. Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305). Int J Hematol. 2010;92(5):713\u201324.","journal-title":"Int J Hematol"},{"issue":"3","key":"1127_CR21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s12185-010-0533-9","volume":"91","author":"K Itoh","year":"2010","unstructured":"Itoh K, Kinoshita T, Watanabe T, Yoshimura K, Okamoto R, Chou T, Ogura M, Hirano M, Asaoku H, Kurosawa M, Maeda Y, Omachi K, Moriuchi Y, Kasai M, Ohnishi K, Takayama N, Morishima Y, Tobinai K, Kaba H, Yamamoto S, Fukuda H, Kikuchi M, Yoshino T, Matsuno Y, Hotta T, Shimoyama M. Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan. Int J Hematol. 2010;91(3):446\u201355.","journal-title":"Int J Hematol"},{"issue":"3","key":"1127_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAP.0b013e31805048fc","volume":"14","author":"JW Said","year":"2007","unstructured":"Said JW. Immunodeficiency-related Hodgkin lymphoma and its mimics. Adv Anat Pathol. 2007;14(3):189\u201394.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"1127_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/COH.0b013e32831a722b","volume":"4","author":"A Carbone","year":"2009","unstructured":"Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS. 2009;4(1):3\u201310.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"1127_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0753-3322(97)86237-3","volume":"52","author":"R Dolcetti","year":"1998","unstructured":"Dolcetti R, Boiocchi M. Epstein\u2013Barr virus in the pathogenesis of Hodgkin\u2019s disease. Biomed Pharmacother. 1998;52(1):13\u201325.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1127_CR25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/mp.53.5.262","volume":"53","author":"KJ Flavell","year":"2000","unstructured":"Flavell KJ, Murray PG. Hodgkin\u2019s disease and the Epstein\u2013Barr virus. Mol Pathol. 2000;53(5):262\u20139.","journal-title":"Mol Pathol."},{"key":"1127_CR26","unstructured":"Weiss LM, von Wasielewski R, Delsol G, Poppema S, Stein H. Mixed cellularity classical Hodgkin lymphoma. WHO Classification Tumors of Haematopoetic and Lymphoid Tissues, 4th ed.; 2008. p 331."},{"issue":"5","key":"1127_CR27","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.micinf.2005.12.012","volume":"8","author":"T Hishima","year":"2006","unstructured":"Hishima T, Oyaizu N, Fujii T, Tachikawa N, Ajisawa A, Negishi M, Nakamura T, Iwamoto A, Hayashi Y, Matsubara D, Sasao Y, Kimura S, Kikuchi Y, Teruya K, Yasuoka A, Oka S, Saito K, Mori S, Funata N, Sata T, Katano H. Decrease in Epstein\u2013Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy. Microbes Infect. 2006;8(5):1301\u20137.","journal-title":"Microbes Infect"},{"key":"1127_CR28","unstructured":"Stein H, Delsol G, Pileris SA, Weiss LM, Poppema S, Jaffe ES. Classical Hodgkin lymphoma, introduction. WHO Classification Tumors of Haematopoetic and Lymphoid Tissues, 4th Ed.; 2008. p 326."},{"issue":"8","key":"1127_CR29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058617","volume":"4","author":"JM Andrieu","year":"1993","unstructured":"Andrieu JM, Roithmann S, Tourani JM, Levy R, Desablens B, le Maignan C, Gastaut JA, Brice P, Raphael M, Taillan B. Hodgkin\u2019s disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Ann Oncol. 1993;4(8):635\u201341.","journal-title":"Ann Oncol"},{"issue":"9","key":"1127_CR30","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19940501)73:9<2400::AID-CNCR2820730925>3.0.CO;2-C","volume":"73","author":"R Rubio","year":"1994","unstructured":"Rubio R. Hodgkin\u2019s disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer. 1994;73(9):2400\u20137.","journal-title":"Cancer"},{"issue":"5","key":"1127_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00042560-200008150-00009","volume":"24","author":"AM Levine","year":"2000","unstructured":"Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin\u2019s disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr. 2000;24(5):444\u201350.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"1127_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00001622-200009000-00009","volume":"12","author":"RF Little","year":"2000","unstructured":"Little RF, Yarchoan R, Wilson WH. Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy. Curr Opin Oncol. 2000;12(5):438\u201344.","journal-title":"Curr Opin Oncol"},{"issue":"30","key":"1127_CR33","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","volume":"23","author":"TH Keegan","year":"2005","unstructured":"Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, et al. Epstein\u2013Barr virus as a marker of survival after Hodgkin\u2019s lymphoma: a population-based study. J Clin Oncol. 2005;23(30):7604\u201313.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1127_CR34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.20.3.630","volume":"20","author":"SJ Horning","year":"2002","unstructured":"Horning SJ, Hoppe RT, Breslin S, Bartlett NL, Brown BW, Rosenberg SA. Stanford V and radiotherapy for locally extensive and advanced Hodgkin\u2019s disease: mature results of a prospective clinical trial. J Clin Oncol. 2002;20(3):630\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1127_CR35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdg152","volume":"14","author":"M Spina","year":"2003","unstructured":"Spina M, Re A, Vaccher E, Gabarre J, Tirelli U. High international prognostic score predicts a worse outcome for patients with Hodgkin\u2019s disease and HIV infection: results of a prospective study with Stanford V regimen. Ann Oncol. 2003;14(4):655\u20136.","journal-title":"Ann Oncol"},{"issue":"9323","key":"1127_CR36","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","volume":"359","author":"N Schmitz","year":"2002","unstructured":"Schmitz N, Pfistner B, Sextro M, Sieber M, Carella AM, Haenel M, Boissevain F, Zschaber R, Muller P, Kirchner H, Lohri A, Decker S, Koch B, Hasenclever D, Goldstone AH, Diehl V. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin\u2019s disease: a randomised trial. Lancet. 2002;359(9323):2065\u201371.","journal-title":"Lancet"},{"issue":"7","key":"1127_CR37","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1182\/blood-2009-02-202762","volume":"114","author":"A Re","year":"2009","unstructured":"Re A, Michieli M, Casari S, Allione B, Cattaneo C, Rupolo M, Spina M, Manuele R, Vaccher E, Mazzucato M, Abbruzzese L, Ferremi P, Carosi G, Tirelli U, Rossi G. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood. 2009;114(7):1306\u201313.","journal-title":"Blood"},{"issue":"1","key":"1127_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","volume":"14","author":"TR Spitzer","year":"2008","unstructured":"Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008;14(1):59\u201366.","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1127-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1127-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1127-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:47Z","timestamp":1559451707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1127-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1127"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1127-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}